financetom
Business
financetom
/
Business
/
Praxis Precision Medicines' movement disorder drug shows promise in trials
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Praxis Precision Medicines' movement disorder drug shows promise in trials
Oct 16, 2025 4:33 AM

Oct 16 (Reuters) - Praxis Precision Medicines ( PRAX )

said on Thursday its experimental drug for movement disorder

helped improve daily functioning in patients in two late-stage

trials.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
180 Life Sciences Regains Nasdaq Compliance
180 Life Sciences Regains Nasdaq Compliance
Oct 10, 2024
09:28 AM EDT, 10/09/2024 (MT Newswires) -- 180 Life Sciences ( ATNF ) said Wednesday it has received notification from Nasdaq that it has regained compliance with the listing rule requiring minimum shareholders' equity of $2.5 million. Shares of the company rose 1.7% in premarket trading. Price: 1.2000, Change: +0.02, Percent Change: +1.69 ...
Sonnet BioTherapeutics Signs Licensing Deal for SON-080 in India; Shares Rise Pre-Bell
Sonnet BioTherapeutics Signs Licensing Deal for SON-080 in India; Shares Rise Pre-Bell
Oct 10, 2024
09:27 AM EDT, 10/09/2024 (MT Newswires) -- Sonnet BioTherapeutics ( SONN ) said Wednesday it has signed a licensing agreement with Alkem Laboratories on SON-080, which is intended for the treatment of diabetic peripheral neuropathy in India. Under the terms of the agreement, Alkem will pay Sonnet an upfront payment of $1 million, as well as up to an additional...
Hurricane impact on Baxter to further constrain IV fluid supply, HHS says
Hurricane impact on Baxter to further constrain IV fluid supply, HHS says
Oct 10, 2024
Oct 9 (Reuters) - Hurricane Helene's impact on Baxter International's ( BAX ) facility will likely lead to further constraints in the supply of intravenous fluids, the U.S. Department of Health and Human Services said on Wednesday. On Sept. 29, medical device maker Baxter said its North Cove site which makes IV fluids, had been affected by hurricane-related flooding and...
Update: Boeing Reportedly Withdraws Pay Offer to Striking Union, Halts Talks
Update: Boeing Reportedly Withdraws Pay Offer to Striking Union, Halts Talks
Oct 10, 2024
09:13 AM EDT, 10/09/2024 (MT Newswires) -- (Updates with details from Boeing's ( BA ) statement in the first and second paragraphs.) Boeing ( BA ) said Wednesday it has withdrawn its recent pay offer of a 30% raise to about 33,000 US workers as negotiations with the striking union broke down. In a letter to employees, Boeing ( BA...
Copyright 2023-2026 - www.financetom.com All Rights Reserved